Results 181 to 190 of about 12,024,061 (386)

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Face-Saving and Depressive Symptoms Among U.S. Chinese Older Adults

, 2020
Dexia Kong, Yin-Ling Irene Wong, XinQi Dong   +2 more
openalex   +2 more sources

Non–Face-to-Face Chronic Care Management: A Qualitative Study Assessing the Implementation of a New CMS Reimbursement Strategy [PDF]

, 2018
Valerie A. Yeager, M. Kristina Wharton, Alisha Monnette, Eboni G. Price‐Haywood, Elizabeth Nauman, Rebekah Angove, Lizheng Shi   +6 more
openalex   +1 more source

Moving face-to-face communication to web-based systems [PDF]

, 2007
Allen, Atkin, Bordia, Burke, Castells, Colgate, Daft, Engel, Gupta, Jane Coughlan, Katz, Kumar, Licklider, Light, Nass, Nayna Patel, Neuhauser, Ramirez, Rasanen, Robert Macredie, Savolainen, Sundar, Tat-Kei Ho, Tubbs, Verhallen, Walther, Warkentin, West, Wilson, Zwass   +29 more
core   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Tumor progression and the different faces of the PERK kinase

, 2015
Dariusz Pytel, Ireneusz Majsterek, J. Alan Diehl   +2 more
openalex   +1 more source

Self-Face Recognition Begins to Share Active Region in Right Inferior Parietal Lobule with Proprioceptive Illusion During Adolescence [PDF]

, 2018
Tomoyo Morita, Daisuke N. Saito, Midori Ban, Koji Shimada, Yuko Okamoto, Hirotaka Kosaka, Hidehiko Okazawa, Minoru Asada, Eiichi Naito   +8 more
openalex   +1 more source

Reconceptualising Space in Academic Lectures: Face-to-Face, Blended and Online Lecturer Discourse in the Context of English-Medium Instruction [PDF]

, 2023
Mariangela Picciuolo
openalex   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source

Neck and Face Surface Electromyography for Prosthetic Voice Control After Total Laryngectomy

, 2009
Cara E. Stepp, James T. Heaton, Rebecca G. Rolland, Robert E. Hillman   +3 more
openalex   +2 more sources